CompletedNCT00134459
Bifeprunox for depression in bipolarity
About this title
Study Evaluating Bifeprunox in Bipolar Depression
Read the official source — NCT00134459Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Birmingham and 39 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJune 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 434
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00134459
- Official title
Show the full official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Beverly Hills · National City
35 more locations
- Stanford
- Farmington Hills
- Bradenton
- Jacksonville
- Orlando
- West Palm Beach
- Smyrna
- Honolulu
- Terre Haute
- Florence
- New Orleans
- Rockville
- Boston
- Saint Charles
- Clementon
- Moorestown
- Lawrence
- New York
- Staten Island
- The Bronx
- Winston-Salem
- Cincinnati
- Dayton
- Lyndhurst
- Oklahoma City
- Tulsa
- Portland
- Philadelphia
- Charleston
- Austin
- Dallas
- Salt Lake City
- Bellevue
- Seattle
- Brown Deer
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wyeth is now a wholly owned subsidiary of Pfizer.
Did this study involve medication?
Yes. The study involved medication, including Bifeprunox and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
